Adverse cutaneous drug reaction to alendronate.
Brinkmeier
Thomas
T
Department of Dermatology, Klinikum Dortmund gGmbH, Dortmund, Beurhausstr. 40, D-44137 Germany. t.brinkmeier@derma.de
Kügler
Katrin
K
Lepoittevin
Jean-Pierre
JP
Frosch
Peter J
PJ
D000284:Administration, Oral; D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D005260:Female; D006257:Head / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D009333:Neck / Q000473:pathology; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D010328:Patch Tests
D050071:Bone Density Conservation Agents; D019386:Alendronate